Viral Hepatitis B and C in North African Countries
|
|
- Annice Howard
- 5 years ago
- Views:
Transcription
1 Viral Hepatitis B and C in North African Countries Prevalence, Risk factors and How to prevent Prof. Ossama Rasslan President, ESIC ICAN, Vice-Chair ICAN 2014, Harare, Zimbabwe, Nov 3rd 5th
2 Overview Viral hepatitis is a serious global public health problem affecting billions of people worldwide. These two diseases are the cause of significant global mortality and morbidity with approximately 1 million deaths each year.
3 Worldwide two billion people have been infected with the HBV and more than 350 million have chronic, lifelong infections. The global burden of disease due to liver cirrhosis and HCC is high (approximately 2% of all deaths). HBV infection varies according to geography, with chronic HBV prevalence ranging from 0.2% to 20%.
4 ? 45% of the world s population lives in highly endemic areas, such as Africa & Asia-Pacific region. Chronic liver disease related to viral hepatitis has emerged as a leading public health problem in the Eastern Mediterranean Region (EMR). Studies indicate that more than 75% of cirrhosis and HCC in the EMR is attributable to HBV or HCV infection.
5 Despite the availability of effective prevention strategies, HBV and HCV transmission occurs throughout EMR. WHO estimates that around 4.3 million persons are infected with HBV and persons with HCV in the EMR each year. Many of these infections are acquired in the health care settings.
6 Prevalence The prevalence of Hepatitis B and C infection was estimated in different regions of Sudan ; Hepatitis B surface antigen was detected in 4.91% of patients, while anti-hepatitis C virus antibodies were detected in 1.82%. In Morocco, HCV and HBV- seropositivity was documented in 1.58% and 1.81%, respectively, among the general population
7 The study in Morocco confirmed the intermediate endemicity for HCV infection and pointed to a decreasing trend of HBV incidence. In Addis Ababa, Ethiopia: Hepatitis B surface antigen was detected in 35.8% and anti-hcv antibody 22.5% patients clinically diagnosed to have chronic liver diseases. The study showed that 2.5% had dual hepatitis B and C virus co-infection.
8 Based on the prevalence of HBV chronic carriers amongst adults in the general population, countries are classified as having low <2%, intermediate 2-8%, or high endemicity >8% of infection (WHO, 2004). Even with the effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas.
9 These groups of chronic carriers include apparently healthy adults, school children, infants, pregnant women, blood donors and healthcare staff (WHO, 2004). Studies in the Middle East showed that the prevalence of HbsAg ranged from 3% to 11% in Egypt.
10
11 The most prevalent genotype in Egypt is genotype D especially in CAH and HCC patients while the mixed type D/F is mostly encountered in AH. The prevalence of hepatitis B surface antigen and anti-hcv antibody was high in patients below 50 years of age.
12 HCV is a viral pandemic and a leading cause of chronic liver disease. Approximately 2% 3% ( million) of the world s population has been infected with HCV. In many developed countries, including USA, the prevalence of HCV infection is <2%. The prevalence is higher (>2%) in Latin America, Eastern Europe, former Soviet Union, and certain countries in Africa, Middle East, and South Asia.
13 Data on HCV infection in Africa are scarce; meaning hepatitis C is still a neglected disease in many countries. Limited data exist in literature on HCV in Africa. Africa has the highest WHO estimated regional HCV prevalence (5.3%). Egypt has the highest prevalence (17.5%) of HCV in the world. ( Review Article in Pan African Medical Journal)
14
15 Risk factors The most common risk factors for hepatitis infection and carrier status are the risk of prenatal transmission. Maternal history of schistosomal infection was significantly associated with the prenatal transmission. The prevalence of anti-hcv and HBsAg among blood donors, in a wide scale multicenter study, was 0.62% and 0.96% respectively.
16 HBV is transmitted by contact with contaminated blood, blood products, and other body fluids (e.g. semen), or through activities that may increase the likelihood of contaminated blood or body fluid exposure. Travelers may be at increased risk due to engaging in casual and unprotected sex, having medical procedures in areas where blood may not be screened, or even through tattoos or acupuncture.
17 The risk for HBV infection in travelers may be higher in countries where the prevalence of chronic HBV infection is high or intermediate.
18 HCV is blood borne and occurs mainly through sharing drug-injection equipment, transfusion of unscreened blood, or untreated clotting factors. In developing countries, unsterile medicinal and other injection practices account for many HCV infections. Although infrequent, HCV can be transmitted through other procedures that involve blood exposure (e.g. tattooing) and during sexual contact.
19 The following activities can result in blood exposure: Receiving blood transfusions that have not been screened for HCV Having medical or dental procedures Activities such as acupuncture, tattooing, public shaving, or injection drug use in which equipment has not been adequately sterilized, or reused.
20 Working in health care fields (medical, dental, or labs) that entail direct exposure to human blood. Unsterile tattooing can transmit hepatitis C virus. People with HCV were found almost four times more likely to report having a tattoo. Hepatitis C can be spread if poor IPC methods are used.
21 Various risk factors for acquiring HCV infection were identified; age, dental treatment, use of glass syringes and surgical history. In addition to these factors, sexual risk behaviors were found to be associated with higher prevalence of hepatitis C.
22
23 Prevention Prevention is the only safeguard against spread of viral hepatitis, through avoiding the practices that increase the risk of infection. A comprehensive strategy is urgently needed to prevent the transmission.
24 Recommended strategies include sustainable Hepatitis B vaccination of all infants within the first 24 hours of life. Protection of HCWs is crucial. Legislation is needed to ensure that all persons with occupational exposure to blood are vaccinated and educated about the risk of blood-borne pathogen transmission.
25 Schools for health care professionals should ensure all students are vaccinated with Hepatitis B vaccine prior to clinical rotations and educate all students about the risk of blood-borne pathogen transmission in HC setting.
26 Urgent efforts are needed to ensure patient safety, injection safety, safe dental care and quality assurance in health care. Studies are needed to characterize the epidemiology of disease, using a unified protocol to enable comparison of data between countries & assess the impact of prevention strategies.
27 Ministries of Health need to take a role in raising parliamentary awareness of the problem and the actions needed, such as legislation, regulations, and financial allocation, to ensure proper implementation of all recommended strategies. Adoption of a regional target of reduction in the prevalence of chronic hepatitis B virus infection to <1% among children over 5 years of age, by 2015.
28 Hepatitis prevention and control programs are multifaceted and may involve immunization, blood screening, injection safety, public health awareness &education, sexual health programs, surveillance, drug &alcohol services, and blood testing &ttt access. Strategic planning and coordination are therefore essential.
29 Lack of accurate prevalence data on hepatitis is widely recognized as inhibiting more effective prevention and control at both international and national levels. Worldwide, one-third of countries have no prevalence data available and more than two-thirds request assistance with surveillance.
30 The diverse components required for effective prevention and control mean that effective programming can be very complex. This complexity also offers opportunities both to integrate viral hepatitis into existing programs and to introduce new policies that may positively impact other high priority public health issues such as HIV/AIDS and intravenous drug use.
31 Hepatitis B vaccine must be given to high risk groups as HCWs especially those having jobs involving exposure to blood and individuals living in low socio-economic standard. Careful screening of blood, blood products, adequate sterilization of reusable surgical and dental instruments, professional and public health education and implementation of IPC practices in all health facilities should be followed to control spread of Hepatitis B.
32 Testing and Treatment Access to testing and treatment is very variable and in some regions both are extremely limited. Just 2 in 5 people live in countries where testing is accessible to more than half of the population, and only 4% of low income countries report that testing is accessible. More than half of the population lives in countries with no provision for free testing and 41% in countries where no government funding exists for treatment of hepatitis B or C.
33 In addition to access to testing, improving diagnosis requires awareness of risks and routes of transmission among those who may have been exposed to hepatitis B or hepatitis C. Innovative examples should provided to improve IPC of viral hepatitis Two-thirds of governments do need assistance in initiating or improving awareness raising activities.
34 Thank you
Viral Hepatitis. WHO Regional Office for Europe July 2013
Viral Hepatitis WHO Regional Office for Europe July 2013 What is Hepatitis? Hepatitis is a viral infection that causes inflammation of the liver There are five main types of viral hepatitis: A, B, C, D,
More informationMedia centre. WHO Hepatitis B. Key facts. 1 of :12 AM.
1 of 5 2013-08-02 7:12 AM Media centre Hepatitis B Share Print Fact sheet N 204 Updated July 2013 Key facts Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic
More informationX-Plain Hepatitis B Reference Summary
X-Plain Hepatitis B Reference Summary Introduction Hepatitis B is the most common serious liver infection. It is caused by the hepatitis B virus that attacks the liver. The virus is transmitted through
More informationyour liver Care for Think about hepatitis
your liver Care for Think about hepatitis World Hepatitis Day 2015 What is hepatitis? Hepatitis is the common name for all inflammatory diseases of the liver. Liver inflammation is most often caused by
More informationVersion for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
More informationJMSCR Volume 03 Issue 01 Page January 2015
www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x Seroprevalence of HBV among HIV Patients and Blood Donors Author Dr. Vedavati B I 1, Dr. Amrutha Kumari B 2, Dr. Venkatesha D 3 Mysore
More informationSIXTY-SECOND WORLD HEALTH ASSEMBLY A62/22 Provisional agenda item April Viral hepatitis. Report by the Secretariat
SIXTY-SECOND WORLD HEALTH ASSEMBLY A62/22 Provisional agenda item 12.17 16 April 2009 Viral hepatitis Report by the Secretariat THE DISEASES AND BURDEN 1. The group of viruses that cause acute and/or chronic
More informationTechnical matters: Viral hepatitis
REGIONAL COMMITTEE Provisional Agenda item 8.6 Sixty-seventh Session SEA/RC67/29 Dhaka, Bangladesh 9 12 September 2014 28 July 2014 Technical matters: Viral hepatitis Viral hepatitis is a serious public
More informationHow does HBV affect the liver?
Hepatitis B Why is the liver important? Your liver is a vital organ that performs many essential functions. It s the largest solid organ in the body and is located under your rib cage on the upper right
More informationTransmission/Prevention
Transmission/Prevention Section Three Transmission/Prevention Hepatitis C is transmitted by blood-to-blood contact. Any break in the skin may allow HCV to enter the body, even if no blood is visible. The
More informationModule 1: HIV epidemiology, transmission and prevention
Session 1 Module goals Module 1 Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationChildren infected with HIV
This Section describes the impact of HIV and AIDS on young children and the extent of the problem. It also provides an overview of how HIV is transmitted to infants and young children. HIV and AIDS can
More informationHepatitis B. Data from the Travel Health Surveillance Section of the Health Protection Agency Communicable Disease Surveillance Centre
Hepatitis B Introduction Hepatitis B virus is one of the most prevalent viruses worldwide and is a major cause of chronic liver disease and hepatocellular carcinoma. It is a hepadnavirus, consisting of
More informationpatients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead:
CONTROLLED DOCUMENT Procedure for the management of patients with blood borne viruses CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled
More informationSummary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017
Summary of Key Points WHO Position Paper on Vaccines against Hepatitis B, July 2017 1 Background l HBV is transmitted by exposure of mucosal membranes or non-intact skin to infected blood, saliva, semen
More informationGlobal Reporting System for Hepatitis (GRSH) An introduction. WHO Global Hepatitis Programme
Global Reporting System for Hepatitis (GRSH) An introduction WHO Global Hepatitis Programme 2018 Objectives 1. Explain the role of the new reporting system 2. Outline the reporting required from countries
More informationNotes Setting the Scene
We need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles in diagnosing patients but also after diagnosis, helping
More informationHepatitis C epidemiology
Hepatitis C epidemiology 3% of world population infected >170 million chronic carriers world-wide > 30 million cases in SEAR ~ 60 million cases in WPR appears to be spreading 3.9 million cases in the USA
More informationVIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...
8 April 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH PROGRAMME SUBCOMMITTEE Sixty-fourth session Brazzaville, Republic of Congo, 9 11 June 2014 Provisional agenda item 6 VIRAL HEPATITIS: SITUATION
More informationHepatitis B vaccination worldwide: Lessons learnt and the way forward
Hepatitis B vaccination worldwide: Lessons learnt and the way forward VHPB Russia meeting Oct 2018 Pierre Van Damme MD, PhD History Hepatitis B vaccines have been available since early 1980 s First recommended
More informationJuly World Hepatitis Day
July 2017- World Hepatitis Day A note from the author Happy July NCP friends! This month, we are going to focus on World Hepatitis Day, which falls on Friday, July 28. 2017. Recently, I have seen many
More informationWe need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles
0 We need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles in diagnosing patients but also after diagnosis, helping
More informationVIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...
5 November 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-fourth session Cotonou, Republic of Benin, 3 7 November 2014 Provisional agenda item 11 VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES
More informationLifetime risk of infection >60% Early childhood infections common
Hepatitis Community Medicine HBV Public health sig HBV is 100 times more infectious than HIV. >350 million chronically infected worldwide. >1 million people die annually of HBV- related chronic liver disease.
More informationHepatitis STARS Program. Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003
Hepatitis 2003 STARS Program Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003 Outline n Hepatitis A Epidemiology and screening Transmission n Hepatitis B Epidemiology
More informationSIXTY-SEVENTH WORLD HEALTH ASSEMBLY A67/13 Provisional agenda item March Hepatitis
SIXTY-SEVENTH WORLD HEALTH ASSEMBLY A67/13 Provisional agenda item 12.3 28 March 2014 Hepatitis Improving the health of patients with viral hepatitis Report by the Secretariat 1. The Executive Board at
More informationHepatitis is an epidemic disease that can be caused by different viruses including hepatitis viruses A, B, C, D or E.
What is Hepatitis? Hepatitis is an epidemic disease that can be caused by different viruses including hepatitis viruses A, B, C, D or E. Hepatitis A and E are not chronic and are mostly present in areas
More informationHepatitis C Best Practice Guidelines For Local Health Departments
Hepatitis C Best Practice Guidelines For Local Health Departments LHDs are responsible for investigating and reporting all physician reported cases of acute hepatitis C (HCV). For clients known to have
More informationToronto Declaration: Strategies to control and eliminate viral hepatitis globally. A call for coordinated action
Toronto Declaration: Strategies to control and eliminate viral hepatitis globally A call for coordinated action Hepatitis B National Action Plan All countries should develop a national and/or regional
More informationDetection of Hepatitis B and C in Primary Care
Detection of Hepatitis B and C in Primary Care Presentation 2 January 2016 Quality Quality Education Education for for aa Healthier Healthier Scotland Scotland 1 1 Learning Outcomes Participants will be
More informationLIVING WITH HEPATITIS B
LIVING WITH HEPATITIS B Welcome What is hep B? Hepatitis B (or hep B) is a serious liver disease that affects millions of people across the world. This brochure is here to help you better understand hep
More informationHEPATITIS B INFECTION and Pregnancy. Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011
HEPATITIS B INFECTION and Pregnancy Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011 HEPATITIS B 26/07/2011 What is Hepatitis B? It is inflammation (infection) of the liver
More informationAwareness regarding hepatitis B immunization among preclinical Indian dental students
Received: 29 Jun. 2013 Accepted: 8 Oct. 2013 Awareness regarding hepatitis B immunization among preclinical Indian dental students Amith Holenarasipur Vasanthakumar MDS 1, Audrey Madonna D Cruz MDS 2 Abstract
More informationViral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital
Viral Hepatitis Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis HAV HBV HCV HDV HEV Other viral: CMV, EBV, HSV Unknown Hepatitis A Hepatitis A Transmitted via the faecal-oral route
More informationkeyword: hepatitis Hepatitis
www.bpac.org.nz keyword: hepatitis Hepatitis Key reviewers: Dr Susan Taylor, Microbiologist, Diagnostic Medlab, Auckland Dr Tim Blackmore, Infectious Diseases Physician and Microbiologist, Wellington Hospital,
More informationHealth Care Workers and Viral Hepatitis in Turkey. Bulent Degertekin M.D. Viral Hepatitis Prevention Board Meeting
Different Aspects of Viral Hepatitis Health Care Workers and Viral Hepatitis in Turkey Bulent Degertekin M.D. Viral Hepatitis Prevention Board Meeting 12 13 November 2009 Istanbul. Turkey Hepatitis B and
More informationEliminating Chronic Hepatitis B Disparities among Asian Pacific Islanders: A Model for Transforming Public Health in the Pacific
Eliminating Chronic Hepatitis B Disparities among Asian Pacific Islanders: A Model for Transforming Public Health in the Pacific Augustina Manuzak, MD, MPH, PhD Augustina.manuzak@doh.hawaii.gov 10/10/2012
More informationViral Hepatitis Burden and Policy Directions in the European Region of WHO
Viral Hepatitis Burden and Policy Directions in the European Region of WHO Dr Nedret Emiroglu WHO Regional Office for Europe Brussels 14-15 October 2010 Global Burden of Chronic Viral Hepatitis 2.7% all
More informationConfirmed (Laboratory Tests) Serum positive for IgM anti-hbc or, hepatitis B surface antigen (HbsAg).
Hepatitis B Hepatitis B is a liver disease that results from infection with the Hepatitis B virus. It can range in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis
More informationChapter 2 Hepatitis B Overview
Chapter 2 Hepatitis B Overview 23 24 This page intentionally left blank. HEPATITIS B OVERVIEW Hepatitis B Virus The hepatitis B virus (HBV) belongs to the Hepadnaviridae family and is known to cause both
More informationResolution. REGIONAL COMMITTEE FOR THE EASTERN MEDITERRANEAN October 2009
WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE Resolution REGIONAL COMMITTEE FOR THE EM/RC56/R.5 EASTERN MEDITERRANEAN October 2009 Fifty-sixth Session Agenda item 6 (a) The growing threats
More informationHepatitis B: What Do Immigrants Need To Know?
B () Hepatitis B: What Do Immigrants Need To Know? Introduction Hepatitis B is an infection of the liver and is caused by the hepatitis B virus. The virus can spread very easily (more easily than the AIDS
More informationProgram to control HIV/AIDS
90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,
More informationHEPATITIS ELIMINATION IN SUB-SAHARAN AFRICA: WHAT WILL IT TAKE?
HEPATITIS ELIMINATION IN SUB-SAHARAN AFRICA: WHAT WILL IT TAKE? Ganiyat Kikelomo OYELEKE FMCP Hepatologist & Gastroenterologist Lagos University Teaching Hospital, Nigeria. INTEREST 2018, KIGALI CONFERENCE
More informationCAPACITY BUILDING TRAINING WORKSHOP ON VIRAL HEPATITIS FOR AFRICAN UNION MEMBER STATES. Cairo, Egypt
المؤسسة اإلفريقية لمرضي الكبد African Liver Patients Association L Association Africaine des Patients atteints d Hépatite Virale CAPACITY BUILDING TRAINING WORKSHOP ON VIRAL HEPATITIS FOR AFRICAN UNION
More informationViral Hepatitis. Background
Viral Hepatitis Background Hepatitis or inflammation of the liver can be caused by infectious and noninfectious problems. Infectious etiologies include viruses, bacteria, fungi and parasites. Noninfectious
More informationHepatitis B and C Basics
Hepatitis B and C Basics What is the liver? The liver is the largest internal organ that performs many important functions. Stores nutrients and vitamins Fights infection Stores energy Removes harmful
More informationHepatitis B at a Glance
Return completed form, preferably within 30 days of U.S. date of arrival, to address on reverse side of this form. Review overseas medical exam if available and document immunization dates. Indicate if
More informationHepatitis B. What is hepatitis B? How is HBV spread?
2015 Hepatitis B Hepatitis B What is hepatitis B? Hepatitis B is a liver condition caused by the hepatitis B virus (HBV). HBV can be chronic, in which case it can lead to liver failure, liver cancer, or
More informationSelected vaccine introduction status into routine immunization
Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF
More informationNIH Consensus Conference Statement. Management of Hepatitis C. March 24-26, NIH Web site. Available at:
ABC s of Hepatitis C Treatment Today Elizabeth N. Britton, MSN, FNP-BC Hepatology Services Louisiana State University Health Sciences Center ebritt@lsuhsc.edu ANAC CONFERENCE -TUCSON NOV 2012 Hepatitis
More informationGreater Glasgow and Clyde. Blood Borne Viruses: Some important basic facts
Greater Glasgow and Clyde Blood Borne Viruses: Some important basic facts Greater Glasgow and Clyde Blood Borne Viruses: Some important basic facts A programme developed by Greater Glasgow and Clyde Health
More informationEAST LONDON INTEGRATED CARE
CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver
More informationViral Hepatitis in Reproductive Health
Viral Hepatitis in Reproductive Health Training Course in Sexual and Reproductive Health Research Geneva 2010 Dr José M Bengoa Dr Pierre Jean Malè Consultants Division of Gastroenterology and Hepatology
More informationLiver Cancer Causes, Risk Factors, and Prevention
Liver Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for liver cancer.
More informationHepatitis B infection
Hepatitis B infection Kenneth Kabagambe Executive Director The National Organization for People Living with Hepatitis B (NOPLHB Uganda General introduction: Viral hepatitis in Uganda Viruses that affect
More informationViral Hepatitis - Historical Perspective
Viral Hepatitis - Historical Perspective Infectious A E Enterically transmitted Viral hepatitis NANB Serum B D F, G,? other C Parenterally transmitted Before the discovery of hepatitis A virus (HAV) and
More informationTB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
More informationCITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE
CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver
More informationHIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME
HIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME Technical considerations and case definitions for VIRAL HEPATITIS SURVEILLANCE Dr Yvan J-F Hutin Global Hepatitis Programme 01 FOUR MAIN HEPATITIS VIRUSES
More informationRheumatic heart disease
EXECUTIVE BOARD EB141/4 141st session 1 May 2017 Provisional agenda item 6.2 Rheumatic heart disease Report by the Secretariat 1. Rheumatic heart disease is a preventable yet serious public health problem
More informationPERINATAL HEPATITIS B
PERINATAL HEPATITIS B A Prevention Strategy Douglas County Health Department, Omaha, NE Why Prevention is Important About 1.25 million people in the U.S. have chronic hepatitis B infection Hepatitis B
More informationHEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38
2016 Annual Morbidity Report HEPATITIS C, ACUTE a Rates calculated based on less than 19 cases or events are considered unreliable b Calculated from: CDC. Notice to Readers: Final 2016 Reports of Nationally
More informationNATIONAL BLOOD TRANSFUSION SERVICES STRATEGY
FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA MINISTRY OF HEALTH NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY February 2005 Addis Ababa Ethiopia Acknowledgement The Ministry of Health of the Federal Democratic
More informationDraft resolution proposed by Brazil, Colombia, Costa Rica, Egypt, Republic of Moldova and South Africa
Draft resolution proposed by Brazil, Colombia, Costa Rica, Egypt, Republic of Moldova and South Africa Resolutions WHA 63.18: Recognized viral hepatitis as a global public health problem; The need for
More informationThe new WHO global injection safety policy and campaign
The new WHO global injection safety policy and campaign B. Allegranzi, SDS, HIS WHO/USAID/PEPFAR hosted webinar 20 August 2015 Overuse of injections and unsafe injection practices worldwide in 2000 (1)
More informationHIV and PEP. LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED
HIV and PEP LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED Disclaimer The views expressed in this presentation are those of the speaker and do not reflect the official policy of the Department
More informationHepatitis Case Investigation
* indicates required fields Does patient also have: Hepatitis Case Investigation West Virginia Electronic Disease Surveillance System Division of Surveillance and Disease Control Infectious Disease Epidemiology
More informationTB epidemic and progress towards the Millennium Development Goals
Open Forum 4: Key issues in TB Drug Development, August 18, 2010, Addis Ababa, Ethiopia TB epidemic and progress towards the Millennium Development Goals Haileyesus Getahun Stop TB Department, WHO Geneva,
More informationViral Hepatitis, 2004
Viral Hepatitis, 24 Key Points Hepatitis A incidence remained low, with 47 cases notified in 24. The number of notifications of hepatitis B continued to increase with 797 cases reported in 24, compared
More informationRisk Factors for HCV Transmission in Pakistan
Risk Factors for HCV Transmission in Pakistan Dr. Saeed Hamid Professor & Chair Department of Medicine Aga Khan University Karachi, Pakistan President, PSSLD Modes of transmission of HCV in Pakistan. Only
More informationSandi Mitchell Nurse Educator Clinical Prevention Services BCCDC
Sandi Mitchell Nurse Educator Clinical Prevention Services BCCDC sandi.mitchell@bccdc.ca Hepatitis A, B and C Testing Transmission Treatment What Is Hepatitis? Hepatitis means inflammation of the liver
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
PAGE 1 of 5 PURPOSE To provide guidelines on the treatment and care of patients with Hepatitis. POLICY Hepatitis is an injury to hepatic cells and an inflammatory process in the liver. The major causes
More informationJackie Williams BBV/Sexual Health Trainer
Jackie Williams BBV/Sexual Health Trainer HEPATITIS The Basics What does your liver do? FUNCTIONS n storage of substances - glycogen, iron and vitamins n disposal of metabolic wastes - urea and bile n
More informationHepatitis C. Kim Dawson October 2010
Hepatitis C Kim Dawson October 2010 Objectives: You will learn: More about Hepatitis C. The importance of the liver. Risk factors and prevention. Signs and symptoms. Hepatitis C Virus: Is a virus that
More informationEpidemiology of Acute Hepatitis C Infection in Canada Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS)
Epidemiology of Acute Hepatitis C Infection in Canada Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS) At a Glance Reported rates of acute HCV declined from.5 per, population in to.
More informationPrevention and control of hepatitis B and C in the European Region of WHO
Prevention and control of hepatitis B and C in the European Region of WHO Viral Hepatitis Prevention Board Dr Nedret Emiroglu WHO Regional Office for Europe Burden of viral hepatitis in the European Region
More informationA Retrospective Study on Seroprevalence of Hepatitis B Surface Antigen among Patients in a Tertiary Care Hospital, South India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 11 (2016) pp. 329-333 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.511.036
More informationPromoting hepatitis B vaccination
Promoting hepatitis B vaccination Introduction Hepatitis B is a serious blood borne infection that can exacerbate hepatitis C infection, can cause serious liver damage and sometimes results in death. Hepatitis
More informationADDRESSING VIRAL HEPATITIS IN PEOPLE WITH SUBSTANCE USE DISORDERS: A THREE (3) PART SERIES
ADDRESSING VIRAL HEPATITIS IN PEOPLE WITH SUBSTANCE USE DISORDERS: A THREE (3) PART SERIES David Njabulo Whiters, PhD, MSW, NCAC II Consultant, Great Lakes Addiction Technology Transfer Center Setting
More informationTime to Eliminate Hepatitis B John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention
Time to Eliminate Hepatitis B John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD, and
More informationHEPATITIS B WHAT YOU NEED TO KNOW ARE YOU SURE YOU USE THE RIGHT MEASURES TO PROTECT YOURSELF AGAINST HEPATITIS B?
HEPATITIS B WHAT YOU NEED TO KNOW ARE YOU SURE YOU USE THE RIGHT MEASURES TO PROTECT YOURSELF AGAINST HEPATITIS B? GET INFORMED! GET VACCINATED! GET PROTECTED! HEPATITIS VACCINE DID YOU KNOW THAT? Hepatitis
More informationin control group 7, , , ,
Q1 Rotavirus is a major cause of severe gastroenteritis among young children. Each year, rotavirus causes >500,000 deaths worldwide among infants and very young children, with 90% of these deaths occurring
More informationLearning Objectives: Hepatitis Update. Primary Causes of Chronic Liver Disease in the U.S. Hepatitis Definition. Hepatitis Viruses.
Learning Objectives: Hepatitis Update ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Upon attendance of this seminar and review of material provided, the attendees will be able to: 1. List hepatitis viruses
More informationIdentification of patients with chronic hepatitis B/C the UK
Identification of patients with chronic hepatitis B/C the UK Will Irving Professor of Virology Chair, Department of Health Advisory Group on Hepatitis Deaths from end stage liver disease, or HCC, in those
More informationHepatitis B Vaccination and Prevention. Angela M. Jo, MD, MSHS
Hepatitis B Vaccination and Prevention Angela M. Jo, MD, MSHS What is Hepatitis B? A virus that lives in blood and other bodily fluids An infectious disease that causes liver disease and cancer 100 x more
More informationOur Liver & Hepatitis
Hepatitis C November 2015 The Liver Hepatitis: A, B & C Outline Epidemiology (Who? How many?) How Hep C Works Transmission & Prevention Testing Treatment 2 What does the liver do? Our Liver & Hepatitis
More informationViral Hepatitis in Ireland, 2005
Viral Hepatitis in Ireland, 25 Key Points Hepatitis A incidence remained low, with 56 cases notified in 25 The number of hepatitis B notifications continued to increase with 95 cases reported in 25, compared
More informationWorld Hepatitis Alliance Strategic Plan 2015
World Hepatitis Alliance Strategic Plan 2015 Overview Foreword The World Hepatitis Alliance is a notfor-profit international umbrella Non- Governmental Organisation (NGO). Our membership is composed of
More informationProvincial Infectious Diseases Advisory Committee Public Health Response to Hepatitis C
Provincial Infectious Diseases Advisory Committee Public Health Response to Hepatitis C Dr. Doug Sider, Medical Director, Public Health Ontario Dr. Peggy Millson, Professor Emeritus, Dalla Lana School
More informationHow has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH
How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH Presentation Outline Big history of global HIV epidemic Current status of HIV and the global AIDS
More informationHepatitis B vaccination: a completed schedule enough to control HBV lifelong? MILAN, ITALY November 2011
Viral Hepatitis Prevention Board Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? MILAN, ITALY 17-18 November 2011 Objectives To review long-term efficacy of hepatitis B vaccine
More informationTOWARDS UNIVERSAL ACCESS
At a glance TOWARDS UNIVERSAL ACCESS Scaling up priority HIV/AIDS interventions in the health sector June 2008 Progress Report This document represents material excerpted from Towards universal access:
More informationPage 221. Corresponding Author: Dr. Nidhi Prasad, Volume 3 Issue - 4, Page No
International Journal of Medical Science and Innovative Research (IJMSIR) IJMSIR : A Medical Publication Hub Available Online at: www.ijmsir.com Volume 3, Issue 4, July - 2018, Page No. : 221-225 Seroprevalence
More informationIncrease Hepatitis B Screening and Vaccinations
17 Increase Hepatitis B Screening and Vaccinations Situation Viral hepatitis is considered to be the most common contagious disease in Japan. Of the estimated three million patients and carriers of viral
More informationGroups at risk for hepatitis B infection - who should be vaccinated
Groups at risk for hepatitis B infection - who should be vaccinated male homosexuals heterosexuals with multiple sex partners (e.g. sex workers) travelers to areas of high HBV endemicity immigrants and
More informationHepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016
Hepatitis B: A Preventable Cause of Liver Cancer Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016 Overview Epidemiology HBV and cancer Screening, Diagnosis
More informationNHS public health functions agreement Service specification No.1 Neonatal hepatitis B immunisation programme
NHS public health functions agreement 2017-18 Service specification No.1 Neonatal hepatitis B immunisation programme NHS public health functions agreement 2017-18 Service specification No.1Neonatal hepatitis
More informationDetection of Hepatitis B and C in Primary Care
Detection of Hepatitis B and C January 2014 Quality Education for a Healthier Scotland 1 Learning Outcomes Participants will be able to:- Identify groups of people who have a higher prevalence of Hepatitis
More information